StemMedical A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About StemMedical A/S
StemMedical A/S (CVR number: 35852808) is a company from GLADSAXE. The company recorded a gross profit of -7902.5 kDKK in 2022. The operating profit was -20.2 mDKK, while net earnings were -18.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -128.3 %, which can be considered poor and Return on Equity (ROE) was -131.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 93.2 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. StemMedical A/S's liquidity measured by quick ratio was 7.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -1 538.84 | -2 061.69 | -3 792.95 | -4 371.01 | -7 902.53 |
EBIT | -3 027.32 | -6 000.32 | -8 620.29 | -14 458.64 | -20 219.09 |
Net earnings | -2 389.80 | -4 083.12 | -7 736.57 | -13 221.37 | -18 876.06 |
Shareholders equity total | 6 265.04 | 5 546.11 | 29 606.49 | 16 385.12 | 12 392.86 |
Balance sheet total (assets) | 8 721.33 | 7 599.90 | 31 148.66 | 18 216.93 | 13 291.61 |
Net debt | -2 691.40 | -1 475.06 | -26 061.87 | -11 108.05 | -5 530.63 |
Profitability | |||||
EBIT-% | |||||
ROA | -37.5 % | -73.5 % | -44.5 % | -58.6 % | -128.3 % |
ROE | -45.3 % | -69.1 % | -44.0 % | -57.5 % | -131.2 % |
ROI | -47.2 % | -93.1 % | -48.7 % | -62.9 % | -140.5 % |
Economic value added (EVA) | -1 955.82 | -4 005.56 | -7 859.00 | -13 319.43 | -19 048.93 |
Solvency | |||||
Equity ratio | 71.8 % | 73.0 % | 95.0 % | 89.9 % | 93.2 % |
Gearing | |||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 2.6 | 2.4 | 17.9 | 7.3 | 7.9 |
Current ratio | 2.6 | 2.4 | 18.0 | 7.8 | 10.0 |
Cash and cash equivalents | 2 691.40 | 1 475.06 | 26 061.87 | 11 108.05 | 5 530.63 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.